BioRestorative Therapies (BRTX) EBITDA Margin (2012 - 2025)
BioRestorative Therapies' EBITDA Margin came in at -19247.27% for Q4 2025, down 13150.79 percentage points from -6096.47% a year earlier but up 11739.10 percentage points from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) EBITDA Margin (2012 - 2025) Analysis & Trends
For FY2025, BioRestorative Therapies' EBITDA Margin was -4291.67%, down 1457.22 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -875.19 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -2834.45% in FY2024 (+7491.37 pp), -10325.82% in FY2023 (+5411.65 pp), -15737.46% in FY2022 (+41259.85 pp) and -56997.32% in FY2021 (-53580.83 pp).
- The five-year range for quarterly EBITDA Margin is -125678.65% (Q4 2022) to -958.36% (Q3 2024).
- Year-over-year, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of -2597.83 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2023 (a gain of 109212.49 percentage points), and the weakest in Q1 2021 (a drop of 80520.89 percentage points).
- Business Quant data shows BRTX's EBITDA Margin at -30986.36% (Q3 2025), -1072.38% (Q2 2025) and -19023.01% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | BioRestorative Therapies | 1.03 Mn | -22.90 Mn | 17,964.00 | -19,247.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -19,247.27% |
| Sep 30, 2025 | -30,986.36% |
| Jun 30, 2025 | -1,072.38% |
| Mar 31, 2025 | -19,023.01% |
| Dec 31, 2024 | -6,096.47% |
| Sep 30, 2024 | -958.36% |
| Jun 30, 2024 | -2,717.29% |
| Mar 31, 2024 | -11,618.68% |
| Dec 31, 2023 | -16,466.16% |
| Sep 30, 2023 | -9,974.91% |
| Jun 30, 2023 | -4,767.48% |
| Mar 31, 2023 | -18,337.85% |
| Dec 31, 2022 | -125,678.65% |
| Sep 30, 2022 | -15,787.84% |
| Jun 30, 2022 | -6,465.70% |
| Mar 31, 2022 | -31,423.64% |
| Dec 31, 2021 | -79,755.42% |
| Sep 30, 2021 | -45,838.88% |
| Jun 30, 2021 | -23,556.19% |
| Mar 31, 2021 | -83,502.53% |
API Access
BioRestorative Therapies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();